Newmed Energy-limited Partnership, IL0004750209

Newmed Energy stock trades at ILS 16.15 with a P/ E of 23.98

Published on 10/13/2026 at 13:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Leviathan working interest is 45.30 percent. Newmed Energy stock trades at ILS 16.15 on October 13, 2026, up 2.47 percent versus ILS 15.76.

Newmed Energy trades at a P/E of 23.98 on October 13, 2026.
Leviathan represents a 45.30 percent working interest in the portfolio.
Newmed Energy stock was ILS 16.15 at 2:18 p.m. IDT, up 2.47 percent from ILS 15.76.
Market capitalization was ILS 19.0 billion, while the 52-week range was ILS 15.34 to ILS 22.90.

Newmed Energy-limited Partnership, IL0004750209, Illustration mit AI erstellt.

Newmed Energy-limited Partnership (IL0004750209) traded at ILS 16.15 on the Tel Aviv Stock Exchange at 2:18 p.m. IDT on October 13, 2026, up 2.47 percent from the previous close of ILS 15.76. The valuation multiple was 23.98, giving the stock report a clear focus beyond the daily move.

Leviathan remains the core asset

NewMed's investor-relations page describes the partnership as a leading participant in Israeli offshore gas and assigns it a 45.30 percent working interest in the Leviathan field. The page also identifies production as the source of cash flow for distributions and business development.

The portfolio spans production, development and exploration assets in the Mediterranean region. That mix means the 45.30 percent Leviathan interest remains the most concrete operating measure in the company's public profile.

Stock stays below its yearly high

The TASE quote stood 29.69 percent below the 52-week high of ILS 22.90 and 5.29 percent above the 52-week low of ILS 15.34 on October 13, 2026. The range places the current quote near the lower end of its yearly trading band.

Market value was ILS 19.0 billion on October 13, 2026. The current P/E of 23.98 compares with a negative 8.23 for Energean and 13.37 for Ratio Energies, so the peer comparison is driven by both earnings differences and the companies' distinct asset bases.

Peer prices rise on October 13

Newmed Energy-limited Partnership: up 2.47 percent, P/E 23.98, market capitalization ILS 19.0 billion
Energean plc (TASE, ILS): up 2.08 percent, P/E minus 8.23, market capitalization ILS 5.5 billion
Ratio Energies - Limited Partnership (TASE, ILS): up 2.17 percent, P/E 13.37, market capitalization ILS 5.3 billion

Valuation sets the market frame

Investing.com lists one analyst in its three-month consensus for Newmed Energy LP, with a Neutral assessment. The page also places the stock's 52-week range between ILS 15.34 and ILS 22.90.

For investors, the useful distinction is between the stock's market position and the underlying gas exposure. NewMed combines a large Leviathan interest with a valuation that is higher than the available peer multiples, while the quote remains 29.69 percent below its yearly high.

What the investor page identifies

NewMed Energy lists NWMD as its stock symbol and identifies the business as focused on energy supply in the Mediterranean region. Global Banking and Finance assigns the security to Tel Aviv under ISIN IL0004750209.

Trading position at ILS 16.15

At 2:18 p.m. IDT on October 13, 2026, Newmed Energy traded at ILS 16.15 on the Tel Aviv Stock Exchange, up 2.47 percent versus the previous close of ILS 15.76. The market capitalization was ILS 19.0 billion and the P/E was 23.98.